SCHEMBL16371024

SCHEMBL16371024

Cc1ccc(OC[C@H](O)CN2CCOCC2)cc1C

nearest known ligand 0.97

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
MAPK1 P28482 2/20 0.70
GAA P10253 2/20 0.70
KMT2A Q03164 4/20 0.70
MAPT P10636 1/20 0.69
USP2 O75604 2/20 0.64
TSHR P16473 2/20 0.64
PKM P14618 1/20 0.63
MEN1 O00255 1/20 0.62
LMNA P02545 1/20 0.60
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16370581 1.00 L3MBTL1 (0.71) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL16370714 1.00 L3MBTL1 (0.71) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
Hydrochloric Acid SCHEMBL16371042 0.99 MAPK1 (0.72) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL22639809 0.89 L3MBTL1 (0.67) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL22639911 0.89 L3MBTL1 (0.67) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL4578170 0.86 USP2 (0.83) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL12834994 0.85 USP2 (0.81) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL4578593 0.83 L3MBTL1 (1.00) L3MBTL1SMN1; SMN2MAPK1GAAKMT2A
SCHEMBL24355399 0.83 KDM4E (0.68) L3MBTL1SMN1; SMN2KMT2AMAPTUSP2
SCHEMBL19182544 0.83 KDM4E (0.68) L3MBTL1SMN1; SMN2KMT2AMAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015004485-A1 THERAPEUTIC COMPOUNDS ISIS INNOVATION LIMITED (GB) 2015-01-15 WO disclosed
WO-2015004485-A1 THERAPEUTIC COMPOUNDS ISIS INNOVATION LIMITED (GB) 2015-01-15 WO disclosed